Frank Litvack

CIK: 0001310715

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (37.5%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAPR

CAPRICOR THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CAPR
CAPRICOR THERAPEUTICS, INC.
May 13, 2026
Exercise(M)
Direct
3.9K shares at avg. $1.39$5K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
50K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 3, 2025
Exercise(M)
Direct
25K shares at avg. $1.39$35K
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 3, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $13.67$35K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
50K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Dec 3, 2024
Exercise(M)
Indirect
20.4K shares at avg. $1.10$22K
CAPR
CAPRICOR THERAPEUTICS, INC.
Dec 2, 2024
Gift(G)
Warrants (Right to Buy)
Direct
20.4K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Dec 2, 2024
Gift(G)
Warrants (Right to Buy)
Indirect
20.4K shares-

		Type	Shares	Price		Ownership
May 13, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	3,937	$1.39	$5,472	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	50,000	-	-	Direct
Mar 3, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	25,000	$1.39	$34,750	Direct
Mar 3, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Tax Payment(F)	2,543	$13.67	$34,763	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	50,000	-	-	Direct
Dec 3, 2024	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	20,391	$1.10	$22,430	Indirect
Dec 2, 2024	CAPR CAPRICOR THERAPEUTICS, INC.	Gift(G) Warrants (Right to Buy)	20,391	-	-	Direct
Dec 2, 2024	CAPR CAPRICOR THERAPEUTICS, INC.	Gift(G) Warrants (Right to Buy)	20,391	-	-	Indirect

1-8 of 8 transactions

About Litvack Frank

Litvack Frank (SEC CIK 0001310715) files insider reports with the SEC as Director of CAPRICOR THERAPEUTICS, INC. (CAPR).

Signal8 holds 5 ownership filings by Litvack Frank, all Form 4s, filed between Dec 4, 2024 and May 14, 2026. Those filings report 8 transactions, from Dec 2, 2024 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Litvack Frank's filings is in SAN DIEGO, CA.

Recent filings by Litvack Frank

May 13, 2026: Option exercise of CAPR shares (Form 4, code M).
Jan 5, 2026: Grant or award of CAPR derivative securities (Form 4, code A).
Mar 3, 2025: Option exercise of CAPR shares (Form 4, code M).
Mar 3, 2025: Tax withholding of CAPR shares (Form 4, code F).
Jan 2, 2025: Grant or award of CAPR derivative securities (Form 4, code A).

Other insiders filing for CAPRICOR THERAPEUTICS, INC. (CAPR)

Krasney Karen, EVP, GENERAL COUNSEL
Bergmann Anthony, CHIEF FINANCIAL OFFICER
Maurer Michael T, CHIEF COMMERCIAL OFFICER
Sabar Karimah Es, Director
Marban Linda, CHIEF EXECUTIVE OFFICER
Auwaerter Paul Gisbert, Director

How to read Form 4 transaction codes